Wound Healing: Initial Healing: Users who apply BPC-157 to support wound healing often see noticeable improvements in wound closure and tissue repair within a week or two, with accelerated healing compared to untreated wounds
J Neurochem (2018) 146(2):17385
Heres a closer look at who can benefit from this treatment
Since insulin therapy often indicates more advanced disease progression, greater severity, or additional comorbidities, which may lead to a higher risk of intestinal obstruction, and there was no statistically significant difference in intestinal obstruction risk between GLP-1RAs and other anti-diabetic medications (e.g., SGLT2 inhibitors, metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors), the observed reduction relative to insulin does not necessarily suggest a protective effect of GLP-1RAs against intestinal obstruction
This is a benefit for small businesses, where unexpected costs can have a much bigger impact